EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Physiological and anatomical determinants of placental drug transfer

Rohan M Lewis iD, Anandita Umapathy, Jane K Cleal iD, Bram G Sengers

The Journal of Physiology · 2026-04-19

DOI: 10.1113/jp289604 ↗

At a glance

Übersichtsarbeit in The Journal of Physiology, published online on 2026-04-19. Written by Rohan M Lewis and 3 co-authors. Institution: Faculty of Medicine, University of Southampton, Southampton, UK. Cited 4 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY 4.0). Funded by: BBSRC, Biotechnology and Biological Sciences Research Council.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Understanding how pharmaceuticals cross the placenta is central to balancing effective maternal therapy with fetal safety. Computational and physiologically based pharmacokinetic models are powerful tools for predicting fetal drug exposure, but their accuracy depends on identifying the rate‐limiting determinants of placental transfer. These include placental anatomy, the routes available for paracellular diffusion, and the cellular localisation and membrane polarisation of drug transporters. The placenta both limits and mediates fetal exposure: it clears pharmaceuticals from the fetal circulation yet provides the principal route by which drugs reach the fetus. Transfer depends on a drug's physicochemical properties, especially molecular size and lipid solubility, and the presence of specific transport mechanisms. Net fetal exposure reflects the combined effects of diffusion and transporter‐mediated fluxes, plasma protein affinity, with a smaller contribution from placental metabolism. At the anatomical level recent advances in our understanding of placental ultrastructure have provided new routes allowing fetal exposure via diffusion. At the molecular level, defining transporter expression and polarisation is challenging and the literature is often inconsistent, reflecting methodological limitations. Single‐cell and single‐nucleus transcriptomics provide valuable insights into cell‐specific gene expression, although not necessarily protein localisation. Spatial mass spectrometry offers complementary information on protein abundance and polarity but remains limited by resolution. Effective models require a strong foundation in physiology and anatomy. A key limitation to modelling placental drug transfer is clearly determining the cellular localisation and membrane polarisation of drug transporters, and addressing this question is key to developing more effective predictive models. image

Subjects

Author keywords

endotheliumplacentasyncytiotrophoblasttransport

Authors and institutions

  • Faculty of Medicine, University of Southampton, Southampton, UK.
  • Institute for Life Sciences, University of Southampton, Southampton, UK.
  • Faculty of Engineering and Physical Sciences, University of Southampton, Southampton, UK.

ORCID profiles: Rohan M Lewis, Jane K Cleal

Funding

  • BBSRC
  • Biotechnology and Biological Sciences Research Council

Cite

APA

Lewis, R. M., Umapathy, A., Cleal, J. K., & Sengers, B. G. (2026). Physiological and anatomical determinants of placental drug transfer. The Journal of Physiology. https://doi.org/10.1113/jp289604

Vancouver

Lewis RM, Umapathy A, Cleal JK, Sengers BG. Physiological and anatomical determinants of placental drug transfer. The Journal of Physiology. 2026. doi:10.1113/jp289604

BibTeX
@article{Lewis2026,
  author = {Lewis, Rohan M and Umapathy, Anandita and Cleal, Jane K and Sengers, Bram G},
  title = {Physiological and anatomical determinants of placental drug transfer},
  journal = {The Journal of Physiology},
  year = {2026},
  doi = {10.1113/jp289604}
}
Start for free →